Ashwin Madupu, MD
Pain Medicine · Muncie, INNPI 1437416310
Payments from drug & device makers
What this record shows
21 manufacturers reported payments, led by Medtronic at 35.7% of the total. Reporting peaked in 2019 at $3,445 and has fallen 80.9% since, to $659 in 2025.
Across 233 payments — averaging $58.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- MML US, Inc.$2K
- Vertos Medical, Inc.$2K
- Vertiflex, Inc.$1K
- Abbott$846
- Relievant Medsystems, Inc.$729
- plus $1K from 15 others
What the payments were for
- Travel & lodging$5,60441%
- Food & beverage$8,12959%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 152 | $4,898 |
| MML US, Inc. | 18 | $2,452 |
| Vertos Medical, Inc. | 9 | $2,170 |
| Vertiflex, Inc. | 10 | $1,390 |
| Abbott | 10 | $846 |
| Relievant Medsystems, Inc. | 6 | $729 |
| Boston Scientific | 6 | $513 |
| Stryker | 3 | $341 |
| GSK | 4 | $67 |
| Nevro Corp. | 2 | $45 |
| Scilex Pharmaceuticals Inc. | 1 | $40 |
| Painteq LLC | 2 | $38 |
| Novo Nordisk | 2 | $33 |
| Bioventus LLC | 1 | $30 |
| SPR Therapeutics, Inc | 1 | $30 |
| Globus Medical | 1 | $26 |
| Saluda Medical Americas, Inc. | 1 | $23 |
| AbbVie | 1 | $21 |
| Johnson & Johnson | 1 | $15 |
| Axonics, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$2,395
- mild Device Kit$2,222
- ReActiv8$2,088
- Superion ISS$1,152
- INTELLIS ADAPTIVESTIM$857
- Proclaim Family of SCS IPGs$668
- KYPHON Balloon Kyphoplasty$615
- VANTA ADAPTIVESTIM$462
- OMNICURVE$168
- VECTRIS$147
- Accurian$142
- WaveWriter Alpha Prime 16$138
- GENERAL PAIN MANAGEMENT$122
- INCEPTIV$104
- SYNCHROMEDII$101
How this compares
$13,733 in reported general payments places this provider in the 85th percentile of 128 pain medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 12 | $530 |
| Pregabalin | 27 | $465 |
| Gabapentin | 13 | $175 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 29 | $158 |
| Methylprednisolone | 21 | $143 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 27 | $130 |
| Levofloxacin | 17 | $54 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Muncie
- Andrew TrobridgeMuncie$253K
- Neal ColemanMuncie$38K
- Derron WilsonCarmel$616K
- Kevin MacadaegCarmel$337K
- Meredith LanghorstFishers$233K
- Abhishek DasMishawaka$186K
- Rajiv TewariFishers$140K
- John SwoffordIndianapolis$127K
- Matthew DevriesLafayette$37K
- Amer KaziGranger$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.